Adverum Biotechnologies, Inc.
ADVMDelisted Dec 9, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001501756
Adverum Biotechnologies, Inc. was delisted on Dec 9, 2025; its insiders filed their last Form 4 on Dec 10, 2025; 50 institutions reported holding it in 13F filings for Q3 2025, worth $63.8M in total; no superinvestor held it.
Q4 2023 vs. Q3 2023
How the institutions holding Adverum Biotechnologies, Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 61 | 61 | 0 |
| Shares | 65.3M | 64.1M | −1.12M (−1.7%) |
| Value | $97.9M | $48.3M | −$49.7M (−50.7%) |
New holders (10)
Institutions that held Adverum Biotechnologies, Inc. at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Soleus Capital Management, L.P. | 425,000 | $319.9K | 0.04% |
| Apexium Financial, LP | 60,000 | $45.2K | 0.00% |
| Squarepoint Ops LLC | 42,334 | $31.9K | 0.00% |
| Citadel Advisors LLC | 33,713 | $25.4K | 0.00% |
| Acadian Asset Management LLC | 27,935 | $20.0K | 0.00% |
| Group One Trading, L.P. | 16,307 | $12.3K | 0.00% |
| IPG Investment Advisors LLC | 10,000 | $7.53K | 0.00% |
| Simplex Trading, LLC | 2,331 | $1.00K | 0.00% |
| Deutsche Bank AG | 18 | $14 | 0.00% |
| Sound Income Strategies, LLC | 10 | $8 | 0.00% |
Sold out (10)
Institutions that held Adverum Biotechnologies, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Citigroup Inc | 476,692 | $715.0K |
| Marshall Wace, LLP | 237,331 | $356.0K |
| Man Group plc | – | $52.6K |
| Jane Street Group, LLC | 33,877 | $50.8K |
| HRT Financial LP | 25,098 | $37.0K |
| Captrust Financial Advisors | 20,500 | $30.8K |
| Cubist Systematic Strategies, LLC | 19,884 | $29.8K |
| Russell Investments Group, Ltd. | 16,000 | $24.0K |
| Ronald Blue Trust, Inc. | 1,500 | $2.00K |
| NBC Securities, Inc. | 500 | $0 |